Enzo Biochem Reports Strong Fiscal Fourth Quarter Results
NEW YORK--(BUSINESS WIRE)--Enzo Biochem Inc. (NYSE:ENZ) today reported results for the fourth quarter and fiscal year ended July 31, 2014, with continued solid year-end gains posted by both Life Sciences and Clinical Labs.
* Fourth quarter revenues increased over the prior year period, despite reduced royalty fee income.
* Gross margins improved year over year across the board resulting in an improvement to 44% in the current quarter from 41% in the prior year period.
Help employers find you! Check out all the jobs and post your resume.
* Fourth quarter revenues increased over the prior year period, despite reduced royalty fee income.
* Gross margins improved year over year across the board resulting in an improvement to 44% in the current quarter from 41% in the prior year period.
Help employers find you! Check out all the jobs and post your resume.